. 2018 Nov 20;78(17):1817–1828. doi: 10.1007/s40265-018-1010-7

Table 3.

Single-tablet regimens available for treating HIV-1 infection in major markets

INSTI-based STRs	Tablet size
Bictegravir/emtricitabine/tenofovir AF	15 × 8 mm
Dolutegravir/abacavir/lamivudine	22 × 11 mm
Elvitegravir/cobicistat/emtricitabine/tenofovir DF	20 × 10 mm
Elvitegravir/cobicistat/emtricitabine/tenofovir AF	19 × 8.5 mm
Dolutegravir/rilpivirine^a	14 × 7 mm

Other STRs	Tablet size
Rilpivirine/emtricitabine/tenofovir DF	19 × 8.5 mm
Rilpivirine/emtricitabine/tenofovir AF	15 × 7 mm
Efavirenz/emtricitabine/tenofovir DF^b	20 × 10.4 mm
Darunavir/cobicistat/emtricitabine/tenofovir AF	22 × 10 mm

AF alafenamide, DF disoproxil fumarate, STRs single-tablet regimens

^aIndicated only for virologically-suppressed patients

^bIn EU, indicated only for virologically-suppressed patients